MacroGenics, Inc. (MGNX)
3.75
-0.05
(-1.32%)
USD |
NASDAQ |
Sep 25, 16:00
3.75
0.00 (0.00%)
After-Hours: 17:54
MacroGenics Cash and Short Term Investments (Quarterly) : 173.30M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 173.30M |
| March 31, 2026 | 154.23M |
| December 31, 2025 | 189.91M |
| September 30, 2025 | 146.40M |
| June 30, 2025 | 176.49M |
| March 31, 2025 | 154.14M |
| December 31, 2024 | 201.67M |
| September 30, 2024 | 200.36M |
| June 30, 2024 | 140.37M |
| March 31, 2024 | 184.24M |
| December 31, 2023 | 229.80M |
| September 30, 2023 | 256.43M |
| June 30, 2023 | 240.35M |
| March 31, 2023 | 241.66M |
| December 31, 2022 | 154.35M |
| September 30, 2022 | 123.62M |
| June 30, 2022 | 133.74M |
| March 31, 2022 | 183.99M |
| December 31, 2021 | 243.62M |
| September 30, 2021 | 298.90M |
| June 30, 2021 | 297.32M |
| March 31, 2021 | 343.18M |
| December 31, 2020 | 272.53M |
| September 30, 2020 | 280.66M |
| June 30, 2020 | 232.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 170.85M |
| December 31, 2019 | 215.76M |
| September 30, 2019 | 254.42M |
| June 30, 2019 | 272.14M |
| March 31, 2019 | 320.39M |
| December 31, 2018 | 232.86M |
| September 30, 2018 | 260.14M |
| June 30, 2018 | 300.89M |
| March 31, 2018 | 260.08M |
| December 31, 2017 | 305.12M |
| September 30, 2017 | 203.65M |
| June 30, 2017 | 243.66M |
| March 31, 2017 | 243.10M |
| December 31, 2016 | 277.00M |
| September 30, 2016 | 311.12M |
| June 30, 2016 | 265.62M |
| March 31, 2016 | 304.45M |
| December 31, 2015 | 339.05M |
| September 30, 2015 | 365.77M |
| June 30, 2015 | 235.03M |
| March 31, 2015 | 263.13M |
| December 31, 2014 | 157.59M |
| September 30, 2014 | 179.19M |
| June 30, 2014 | 194.01M |
| March 31, 2014 | 198.72M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 4.882B |
| Xencor, Inc. | 456.45M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |